Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Thetis Pharmaceuticals logo — Resolving disease without compromising host defense

Thetis Pharmaceuticals

Resolving disease without compromising host defense

Founded 2011 United States Essex, United States 4 employees Grant Total: $22.87M Biotechnology, Pharmaceutical

General Information

Company Name Thetis Pharmaceuticals
Founded Year 2011
Location United States Essex, United States
Employees 4
Industries Biotechnology, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Thetis Pharmaceuticals. To contact Thetis Pharmaceuticals, visit thetispharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Thetis Pharmaceuticals compare?

A PDF of Thetis Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Thetis Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Thetis Pharmaceuticals

Thetis Pharmaceuticals is a biopharmaceutical company founded in 2011 and headquartered in the United States. The company's slogan, "Thetis is developing novel therapies that resolve inflammation without compromising immune function," encapsulates its core mission. Thetis is focused on developing first-in-class Resolvin therapies for the treatment of cancer and autoimmune diseases. These Resolvins are unique endogenous molecules that play a key role in regulating immune homeostasis. The latest investment secured by Thetis Pharmaceuticals amounted to $4.20M, in the form of a grant investment on 05 April 2022. This funding was provided by The Leona M. and Harry B. Helmsley Charitable Trust, showcasing the confidence that leading organizations have in Thetis's innovative approach to addressing inflammation and immune function. Thetis Pharmaceuticals operates within the Biotechnology and Pharmaceutical industries, where its groundbreaking work in developing therapies for cancer and autoimmune diseases holds significant promise. With its focus on resolving inflammation while maintaining immune function, Thetis is poised to make a meaningful impact in improving treatment options for these challenging medical conditions.

Business keywords: biopharmaceutical, therapies, inflammation resolution, immune function, cancer treatment, autoimmune diseases, Resolvin therapies, endogenous molecules, immune homeostasis, medical research, drug development

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.20M 1
The Leona M. and Harry B. Helmsley Charitable Trust
05 Apr 2022
Grant $2.30M 1
National Institutes of Health
24 Oct 2019
Grant $1.90M 1
National Institutes of Health
23 May 2018
Grant $2.30M 1
National Institutes of Health
16 Nov 2017
Venture Round $3.33M -
27 Jun 2016
Debt Financing $1.43M -
11 Feb 2016
Venture Round Undisclosed 1
River Valley Investors
River Valley Investors
01 Jul 2013
Venture Round $5.67M -
18 Dec 2012
Seed Round $1.74M 2
Connecticut Innovations Stonehenge Capital Company
Connecticut Innovations, Stonehenge Capital Company
12 Aug 2011

Thetis Pharmaceuticals Alternatives & Competitors

View All Alternatives
Thetis Pharmaceuticals vs
Biond Biologics Ltd
Biond Biologics Ltd Israel

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the tre...

Series C
43 employees
Biotechnology, Health Care
Thetis Pharmaceuticals vs
Nirogy Therapeutics
Nirogy Therapeutics

Pioneering innovative small molecules to disrupt metabolic and immune pathways, advancing therapeuti...

Series A
2-10 employees
Biopharma, Biotechnology
Thetis Pharmaceuticals vs
Emergo Therapeutics
Emergo Therapeutics United States

Bringing the Immune Response Back into Balance

Venture round
5 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Thetis Pharmaceuticals

Resolving disease without compromising host defense
Thetis Pharmaceuticals was founded in 2011.
Thetis Pharmaceuticals is headquartered in Essex, United States.
Thetis Pharmaceuticals operates in Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, therapies, inflammation resolution and immune function.
Thetis Pharmaceuticals has approximately 4 employees.
Thetis Pharmaceuticals has completed 9 funding rounds, raising a total of $22.87M. The latest funding stage is Grant.
Top alternatives and competitors to Thetis Pharmaceuticals include Biond Biologics Ltd, Nirogy Therapeutics, Emergo Therapeutics, Apollomics, Sepsia Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thetis Pharmaceuticals and Biond Biologics Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Thetis Pharmaceuticals, https://bouncewatch.com/company/thetis-pharmaceuticals, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout